Dublin, California
United States
35
2012-03-08
20
2014-04-29
These are the the leading inventors for applications assigned to SuperGen, Inc.:
SuperGen, Inc. based in Dublin, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IMIDAZO[1,2-B]PYRIDAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
#2 | 2011-11-17 ✅ Patent 8,710,057 granted on 2014-04-29Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitors
#3 | 2011-11-03AXL KINASE INHIBITORS
#4 | 2011-10-20QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION
#5 | 2011-04-14 ✅ Patent 8,445,502 granted on 2013-05-21Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
#6 | 2010-09-09IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
#7 | 2010-05-27QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION
#8 | 2010-03-11Salts of 5-Azacytidine
#9 | 2009-11-19 ✅ Patent 7,939,546 granted on 2011-05-10Quinoline derivatives for modulating DNA methylation
#10 | 2009-06-04Protein Kinase Inhibitors
#11 | 2009-04-16 ✅ Patent 7,790,746 granted on 2010-09-07Quinoline derivatives for modulating DNA methylation
#12 | 2009-01-29PROTEIN KINASE INHIBITORS
#13 | 2008-11-27 ✅ Patent 7,998,966 granted on 2011-08-16Axl kinase inhibitors
#14 | 2008-10-23 ✅ Patent 7,750,007 granted on 2010-07-06Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
#15 | 2008-09-18 ✅ Patent 7,820,684 granted on 2010-10-26Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
#16 | 2008-09-04PYRIMIDINE-2,4-DIAMINE DERIVATIVES AND THEIR USE AS JAK2 KINASE INHIBITORS
#17 | 2008-08-28PROTEIN KINASE INHIBITORS
#18 | 2008-07-24QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION
#19 | 2007-03-29 ✅ Patent 7,700,567 granted on 2010-04-20Oligonucleotide analogues incorporating 5-aza-cytosine therein
#20 | 2006-12-05 ✅ Patent 7,144,873 granted on 2006-12-05Kit for delivering decitabine in vivo
#21 | 2006-11-23Inhibitors of polo-like kinase-1
#22 | 2006-11-14 ✅ Patent 7,135,464 granted on 2006-11-14Method of administering decitabine
#23 | 2006-09-14 ✅ Patent 7,250,416 granted on 2007-07-31Azacytosine analogs and derivatives
#24 | 2006-07-04 ✅ Patent 7,071,202 granted on 2006-07-04Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
#25 | 2006-06-13 ✅ Patent 7,060,290 granted on 2006-06-13Phosphocholine linked prodrug derivatives
#26 | 2006-05-23 ✅ Patent 7,049,322 granted on 2006-05-23Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
#27 | 2006-05-02 ✅ Patent 7,037,900 granted on 2006-05-02Composition and method for treating graft-versus-host disease
#28 | 2006-03-23Salts of 5-azacytidine
#29 | 2006-01-19Compositions and formulations of decitabine polymorphs and methods of use thereof
#30 | 2006-01-03 ✅ Patent 6,982,253 granted on 2006-01-03Liquid formulation of decitabine and use of the same
#31 | 2005-12-20 ✅ Patent 6,977,247 granted on 2005-12-20Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
#32 | 2005-10-13 ✅ Patent 7,326,712 granted on 2008-02-05Substituted tricyclic compounds as protein kinase inhibitors
#33 | 2005-07-21 ✅ Patent 7,276,228 granted on 2007-10-02Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase
#34 | 2005-06-14 ✅ Patent 6,905,669 granted on 2005-06-14Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
#35 | 2005-02-24Pharmaceutical formulation
177991 ⎘